These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 13197751)

  • 1. Activation of pyrazinamide and nicotinamide in acidic environments in vitro.
    McDERMOTT W; TOMPSETT R
    Am Rev Tuberc; 1954 Oct; 70(4):748-54. PubMed ID: 13197751
    [No Abstract]   [Full Text] [Related]  

  • 2. The intracellular activation of pyrazinamide and nicotinamide.
    MACKANESS GB
    Am Rev Tuberc; 1956 Nov; 74(5):718-28. PubMed ID: 13372956
    [No Abstract]   [Full Text] [Related]  

  • 3. The antituberculous activity of pyrazinamide in vitro and in the guinea pig.
    STEENKEN W; WOLINSKY E
    Am Rev Tuberc; 1954 Aug; 70(2):367-9. PubMed ID: 13180876
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of significant in vitro sensitivity of Mycobacterium tuberculosis to pyrazinamide on three different solid media.
    TARSHIS MS; WEED WA
    Am Rev Tuberc; 1953 Mar; 67(3):391-5. PubMed ID: 13031058
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro determination of the antimycobacteric activity of pyrazinamide].
    BASILICO F; BOSISIO E; GRASSI C
    G Ital Della Tuberc; 1956; 10(4):225-7. PubMed ID: 13366033
    [No Abstract]   [Full Text] [Related]  

  • 6. [Production of resistance of m. tuberculosis against rimiform in vitro].
    NIGOGHOSSIAN GA
    Schweiz Med Wochenschr; 1952 Jul; 82(27):706-7. PubMed ID: 14950250
    [No Abstract]   [Full Text] [Related]  

  • 7. A new method for the differentiation of human tubercle bacilli from other types of mycobacteria, using nicotinamide-containing medium (nicotinamide test). A preliminary report.
    TAN THIAM HOK
    Am Rev Respir Dis; 1962 Jul; 86():94. PubMed ID: 13919439
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro studies on isonicotinic acid hydrazide.
    PANSY F; STANDER H; DONOVICK R
    Am Rev Tuberc; 1952 Jun; 65(6):761-4. PubMed ID: 14924200
    [No Abstract]   [Full Text] [Related]  

  • 9. The anti-tuberculous activity of some derivatives of p-aminosalicylic acid, nicotinic acid, and isonicotinic acid.
    THAYER JD; SELIGMAN RB
    Antibiot Chemother (Northfield); 1955 Mar; 5(3):129-31. PubMed ID: 24543399
    [No Abstract]   [Full Text] [Related]  

  • 10. [Niacin test and nicotinamide test in isoniazid resistant strains of Mycobacterium tuberculosis].
    Hergt R; Ogbuoto G; Nimmich W
    Z Tuberk Erkr Thoraxorg; 1968 Dec; 129(5):329-34. PubMed ID: 4239321
    [No Abstract]   [Full Text] [Related]  

  • 11. [Certain aspects of metabolism in vitro of nicotinamide].
    PORCELLATI G; QUAGLIARIELLO G
    Boll Soc Ital Biol Sper; 1955; 31(9-10):1330-4. PubMed ID: 13329114
    [No Abstract]   [Full Text] [Related]  

  • 12. Relation between in-vitro and in-vivo resistance to isoniazid.
    GOULDING R; KING MB; KNOX R; ROBSON JM
    Lancet; 1952 Jul; 2(6724):69-70. PubMed ID: 14939829
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity of N-isonicotinoyl-N'-(salicylidene) hydrazine (salizid) against Mycobacterium tuberculosis.
    HART JJ; RUTHERFORD G; ANDERSON FE; BARKLEY FA; MAST GW
    Antibiot Chemother (Northfield); 1954 Jul; 4(7):803-8. PubMed ID: 24543179
    [No Abstract]   [Full Text] [Related]  

  • 14. ISONIAZID trials.
    Lancet; 1952 Sep; 2(6732):471-2. PubMed ID: 14956048
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of N-isonicotinoyl-N'-(2,2-dimethyl-3-hydroxypropylidene) hydrazine (pivalizid) against Mycobacterium tuberculosis.
    HART JJ; RUTHERFORD G; ANDERSON FE; BARKLEY FA; MAST GW
    Antibiot Chemother (Northfield); 1954 Jul; 4(7):813-7. PubMed ID: 24543181
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental study of the effects of nicotinamide on tuberculosis].
    LEVADITI C; VAISMAN E
    C R Hebd Seances Acad Sci; 1952 Apr; 234(15):1588-90. PubMed ID: 12979295
    [No Abstract]   [Full Text] [Related]  

  • 17. Pyrazinamide-isoniazid in tuberculosis. III. Observations with reduced dosage of pyrazinamide.
    MUSCHENHEIM C; ORGANICK A; MCCUNE RM; BATTEN J; DEUSCHLE K; TOMPSETT R; MCDERMOTT W
    Am Rev Tuberc; 1955 Dec; 72(6):851-5. PubMed ID: 13268857
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vitro effect of isonizide on Mycobacterium tuberculosis].
    BRUN J; VIALLIER J
    C R Seances Soc Biol Fil; 1952 Sep; 146(17-18):1332-4. PubMed ID: 13020157
    [No Abstract]   [Full Text] [Related]  

  • 19. The development of drug resistance of M. tuberculosis to isonicotinic acid hydrazide.
    BUCK M; SCHNITZER RJ
    Am Rev Tuberc; 1952 Jun; 65(6):759-60. PubMed ID: 14924199
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of pyrazinamide (aldinamide) on experimental tuberculosis in mice.
    MALONE L; SCHURR A; LINDH H; McKENZIE D; KISER JS; WILLIAMS JH
    Am Rev Tuberc; 1952 May; 65(5):511-8. PubMed ID: 14924173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.